ArticleProceedings of the National Academy of Sciences of the United States of America2014

Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer.

Cale D Fahrenholtz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.